Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

2608

LikeLikedUnlike

Episodes 211-225 of 745

Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML 
MinuteCE®
Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
MinuteCE®
Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Managing Adverse Events Associated With Menin Inhibitors 
MinuteCE®
Managing Adverse Events Associated With Menin Inhibitors 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Applying Evidence to Clinical Practice 
MinuteCE®
Applying Evidence to Clinical Practice 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Emerging Directions in Menin-Directed AML Therapy 
MinuteCE®
Emerging Directions in Menin-Directed AML Therapy 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
Ongoing Clinical Trials in AML With Menin Inhibitors 
MinuteCE®
Ongoing Clinical Trials in AML With Menin Inhibitors 
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
advertisement
Expert Recommendations and Key Takeaways
MinuteCE®
Expert Recommendations and Key Takeaways
- Ghayas Issa, MD
  Peer
- Amir Fathi, MD
  Peer
1.00 program credits
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
CME/CE
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
- Ahmad Masri, MD, MS
  Peer
Advancing Molecular Therapies to First Line in BRAF-Mutated mCRC: Insights From Emerging Data
MinuteCE®
Advancing Molecular Therapies to First Line in BRAF-Mutated mCRC: Insights From Emerging Data
- Scott Kopetz, MD, PhD
  Peer
- Cathy Eng, MD, FACP
  Peer
1.00 program credits
Case Consult: Current Standards and Emerging Directions in BRAF-Mutant mCRC Care
MinuteCE®
Case Consult: Current Standards and Emerging Directions in BRAF-Mutant mCRC Care
- Scott Kopetz, MD, PhD
  Peer
- Cathy Eng, MD, FACP
  Peer
1.00 program credits
Maximizing Outcomes: Strategic Approaches in Metastatic CRC Treatment
MinuteCE®
Maximizing Outcomes: Strategic Approaches in Metastatic CRC Treatment
- Scott Kopetz, MD, PhD
  Peer
- Cathy Eng, MD, FACP
  Peer
1.00 program credits
Optimize Outcomes in CKD & T2D: A Practical Approach to Initiating and Monitoring Combination ns-MRA & SGLT2i Therapy
CME/CE
Optimize Outcomes in CKD & T2D: A Practical Approach to Initiating and Monitoring Combination ns-MRA & SGLT2i Therapy
- Amy Mottl, MD, MPH
  Peer
- Prof. Christoph Wanner
  Peer
0.25 credits
advertisement
Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy
CME/CE
Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy
- Kevin Kalinsky MD, MS
  Peer
- Komal Jhaveri, MD, FACP
  Peer
0.50 credits
MinuteCE®
Advancing Patient-Centered Care in PAH
- H. James Ford, MD
  Peer
- Martha Kingman, DNP, FNP-C
  Peer
- Jean M. Elwing, MD
  Peer
- Hilary M. DuBrock, MD
  Peer
1.00 credits 10 episodes
The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
MinuteCE®
The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
- H. James Ford, MD
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended